Priority Pharmaceuticals
Closed
17 Academy St Ste 308
Newark, NJ 07102
Cornerstone Pharmaceuticals Inc., based in Monmouth Junction, New Jersey, is focused on anti-metabolic cancer therapy. The company is currently evaluating its lead drug candidate, CPI-613 devimistat, through combinations in preclinical cancer models.
With a commitment to innovative research and development, Cornerstone Pharmaceuticals aims to advance its portfolio of drug candidates, including CB-839 and telaglenastat. The organization is dedicated to exploring novel therapeutic approaches in the ongoing fight against cancer.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Foursquare.
